ENDRA Life Sciences (NDRA) Intangibles (2025 - 2026)
ENDRA Life Sciences' (NDRA) quarterly Intangibles came in at $1.9 million in Q2 2026, down 21.63% quarter-over-quarter from $2.4 million in Q1 2026.
Analysis
ENDRA Life Sciences (NDRA) Intangibles (2025 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Intangibles for 2 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Intangibles changed N/A year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.0 million, changed N/A from the prior year.
- Intangibles was $1.9 million for Q2 2026 at ENDRA Life Sciences, down from $2.4 million in the prior quarter.
- Over five years, Intangibles peaked at $2.4 million in Q1 2026 and troughed at $1.9 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 1.89 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 936.40 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 1.69 Bn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 6.82 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 12.40 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 2.68 Bn |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | 1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.90 Mn |
| Mar 31, 2026 | 2.43 Mn |
| Dec 31, 2025 | 2.01 Mn |